Haemonetics Corporation Goodwill, Acquired During Period
Haemonetics Corporation (HAE) reported Goodwill, Acquired During Period of $50.48 million for the 12-month period ending 2026-03-28, per its 10-K filed 2026-05-20.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2026-05-20
- Haemonetics Corporation goodwill, acquired during period for the quarter ending 2025-03-29 was $0.00.
- Haemonetics Corporation goodwill, acquired during period for the quarter ending 2024-12-28 was $0.00.
- Haemonetics Corporation goodwill, acquired during period for the quarter ending 2024-09-28 was $0.00.
- Haemonetics Corporation goodwill, acquired during period for the quarter ending 2024-06-29 was $69.54M.
- Haemonetics Corporation goodwill, acquired during period for fiscal 2026 was $50.48M, a 27.41% decline from fiscal 2025.
- Haemonetics Corporation goodwill, acquired during period for fiscal 2025 was $69.54M, a 20.14% decline from fiscal 2024.
- Haemonetics Corporation goodwill, acquired during period for fiscal 2024 was $87.08M.
- Haemonetics Corporation goodwill, acquired during period for fiscal 2021 was $259.79M, a 0.00% change from fiscal 2020.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2026-03-28 | $50.48M 10-K · filed 2026-05-20 | |||
| 2025-03-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $0.00 derived: sum of 2 quarters · filed 2026-05-20 | $0.00 derived: sum of 3 quarters · filed 2026-05-20 | $69.54M 10-K · filed 2026-05-20 |
| 2024-12-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06 | $0.00 derived: sum of 2 quarters · filed 2025-02-06 | $69.54M 10-Q · filed 2025-02-06 | $69.54M derived: sum of 4 quarters · filed 2025-05-21 |
| 2024-09-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $69.54M 10-Q · filed 2024-11-07 | $69.54M derived: sum of 3 quarters · filed 2025-05-21 | |
| 2024-06-29 | $69.54M 10-Q · filed 2024-08-08 | $69.54M derived: sum of 2 quarters · filed 2025-05-21 | ||
| 2024-03-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-21 | $87.08M 10-K · filed 2025-05-21 | ||
| 2023-12-30 | $87.08M 10-Q · filed 2024-02-08 | |||
| 2021-04-03 | $259.79M 10-K · filed 2022-05-25 | |||
| 2020-03-28 | $259.79M 10-K · filed 2021-05-26 | |||
| 2014-03-29 | $6.42M 10-K · filed 2015-05-22 | |||
| 2013-03-30 | $216.94M 10-K · filed 2014-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |